Modulation of the kallikrein/kinin system by the angiotensin-converting enzyme inhibitor alleviates experimental autoimmune encephalomyelitis.

scientific article published in November 2014

Modulation of the kallikrein/kinin system by the angiotensin-converting enzyme inhibitor alleviates experimental autoimmune encephalomyelitis. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/CEI.12413
P932PMC publication ID4233374
P698PubMed publication ID24996009
P5875ResearchGate publication ID263705641

P2093author name stringM Mori
A Uzawa
S Kuwabara
J Taniguchi
P2860cites workAngiotensin II increases human monocyte matrix metalloproteinase-1 through the AT2 receptor and prostaglandin E2: implications for atherosclerotic plaque ruptureQ28173922
Activation of kinin receptor B1 limits encephalitogenic T lymphocyte recruitment to the central nervous systemQ28250134
Multiple sclerosisQ28299151
Angiotensin II sustains brain inflammation in mice via TGF-betaQ34028682
Bradykinin receptor ligands: therapeutic perspectivesQ35906110
Role of the renin-angiotensin system in autoimmune inflammation of the central nervous systemQ37329566
Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity.Q37329670
CSF angiotensin II and angiotensin-converting enzyme levels in anti-aquaporin-4 autoimmunityQ39694148
Comparative effects of AT1-antagonism and angiotensin-converting enzyme inhibition on markers of inflammation and platelet aggregation in patients with coronary artery diseaseQ44984910
Enalapril attenuates angiotensin II-induced atherosclerosis and vascular inflammationQ45177967
IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitisQ47733403
Captopril and lisinopril suppress production of interleukin-12 by human peripheral blood mononuclear cellsQ47809769
Site-specific production of IL-6 in the central nervous system retargets and enhances the inflammatory response in experimental autoimmune encephalomyelitisQ48524409
Anti-high mobility group box 1 monoclonal antibody ameliorates experimental autoimmune encephalomyelitis.Q51825933
Angiotensin-converting enzyme I/D gene polymorphism and risk of multiple sclerosis.Q54573054
Kinin B1 receptor expression and function on human brain endothelial cellsQ57042328
Effects of Inhibitors of the Renin-Angiotensin System on the Efficacy of Interferon beta-1b: A post hoc Analysis of the BEYOND StudyQ57911711
Effects of the angiotensin converting enzyme inhibitor captopril on experimental autoimmune encephalomyelitisQ70938397
Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failureQ73250285
Serum angiotensin-converting enzyme in multiple sclerosisQ73617156
IL-17 plays an important role in the development of experimental autoimmune encephalomyelitisQ79755041
P433issue2
P304page(s)245-252
P577publication date2014-11-01
P1433published inClinical and Experimental ImmunologyQ15716708
P1476titleModulation of the kallikrein/kinin system by the angiotensin-converting enzyme inhibitor alleviates experimental autoimmune encephalomyelitis.
P478volume178

Reverse relations

cites work (P2860)
Q64103422Bradykinin receptor deficiency or antagonism do not impact the host response during gram-negative pneumonia-derived sepsis
Q38314732Critical insights into the beneficial and protective actions of the kallikrein-kinin system
Q47720411Implication of the Kallikrein-Kinin system in neurological disorders: Quest for potential biomarkers and mechanisms
Q35406226Local bone interaction between renin-angiotensin system and kallikrein-kinin system in diabetic rat.
Q52330367The complex alteration in the network of IL-17-type cytokines in patients with hereditary angioedema.

Search more.